Skip to main content
SpringerLink
Log in
Book cover

Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health pp 37–72Cite as

Rating Scales for Anxiety Disorders

  • Chapter
  • First Online:

Part of the book series: Current Clinical Psychiatry ((CCPSY))

Abstract

Anxiety is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association (Diagnostic and Statistical Manual of Mental Disorders, 2000)) as an “apprehensive anticipation of future danger or misfortune accompanied by a feeling of dysphoria or somatic symptoms of tension” (American Psychiatric Association (Diagnostic and Statistical Manual of Mental Disorders, 2000 p. 820)). The anxiety disorders in the DSM-IV include panic disorder with and without agoraphobia, generalized anxiety disorder, social phobia, specific phobia, posttraumatic stress disorder, and obsessive compulsive disorder. Measures for evaluating anxiety disorders can be useful in clinical practice and research as a tool for measuring change due to treatment, comparing disorder severity and symptom presentation across groups, motivating patients by systematically discussing the extent of their symptoms and impairment, and informing the clinician of symptom presentation and areas of impairment in each individual patient. This chapter is designed to aid clinicians and researchers in choosing empirically driven measures to guide their clinical and research endeavors for each of the aforementioned anxiety disorders. Whenever appropriate, measures are reprinted to facilitate this process.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth, Text Revision ed. 2000, Washington, DC: American Psychiatric Association.

    Google Scholar 

  2. Brown, T.A., P.A. Di Nardo, and D.H. Barlow, Anxiety Disorders Interview Schedule for DSM-IV. 1994, San Antonio, TX: The Psychological Corporation.

    Google Scholar 

  3. First, M.B., et al., Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Editions (SCID-I/P, Version 2.0). 1996, New York: Biometrics Research Department, New York State Psychiatric Institute.

    Google Scholar 

  4. Blanchard, E.B., et al., The utility of the Anxiety Disorders Interview Schedule (ADIS) in the diagnosis of the Post-traumatic Stress Disorder (PTSD) in Vietnam veterans. Behaviour Research and Therapy, 1986. 24(5): pp. 577–580.

    Article  PubMed  Google Scholar 

  5. Bouman, T.K. and C. de Ruiter, The validity of the Anxiety Disorders Interview Schedule-Revised (ADIS-R): A pilot study. Gedragstherapie, 1991. 24(2): pp. 77–88.

    Google Scholar 

  6. Grisham, J.R., T.A. Brown, and L.A. Campbell, The Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV), in Comprehensive handbook of psychological assessment, Vol 2: Personality assessment. 2004, John Wiley & Sons, Inc: Hoboken, NJ. pp. 163–177.

    Google Scholar 

  7. First, M.B. and M. Gibbon, The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II), in Comprehensive handbook of psychological assessment, Vol 2: Personality assessment. 2004, John Wiley & Sons, Inc: Hoboken, NJ. pp. 134–143.

    Google Scholar 

  8. Sheehan, D.V., et al., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 1998. 59 Suppl 20: pp. 22–33;quiz 34–57.

    PubMed  Google Scholar 

  9. Beck, A.T., et al., An Inventory for Measuring Clinical Anxiety: Psychometric Properties. Journal of Consulting & Clinical Psychology, 1988. 56(6): pp. 893–897.

    Article  Google Scholar 

  10. Cox, B.J., et al., Does the Beck Anxiety Inventory measure anything beyond panic attack symptoms? Behaviour Research & Therapy, 1996. 34(11–12): pp. 949–54; discussion 955–61.

    Article  Google Scholar 

  11. Beck, A.T. and R.A. Steer, Beck Inventory Manual. 1993, San Antonio, TX: Psychological Coorporation.

    Google Scholar 

  12. de Beurs, E., et al., Convergent and divergent validity of the Beck Anxiety Inventory for patients with panic disorder and agoraphobia. Depression & Anxiety, 1997. 6(4): pp. 140–6.

    Article  PubMed  Google Scholar 

  13. Creamer, M., et al., The Beck Anxiety Inventory in a non-clinical sample. Behaviour Research & Therapy, 1995. 33(4): pp. 477–85.

    Article  Google Scholar 

  14. Leyfer, O.T., et al., Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. Journal of Anxiety Disorders, 2006. 20(4): pp. 444–58.

    Article  PubMed  Google Scholar 

  15. Dattilio, F.M. and J. Salas-Auvert, Panic Disorder: Assessment and treatment through a wide-angle lens. 2000, Phoenix, AZ: Zeig, Tucker & Co.

    Google Scholar 

  16. Shear, M.K., et al., Panic Disorder Severity Scale (PDSS). 1992, Pittsburg, PA: Department of Psychiatry, University of Pittsburg School of Medicine.

    Google Scholar 

  17. Shear, M.K., et al., Reliability and validity of the Panic Disorder Severity Scale: replication and extension. Journal of Psychiatric Research, 2001. 35(5): pp. 293–6.

    Article  PubMed  Google Scholar 

  18. Pollack, M.H., et al., Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Archives of General Psychiatry, 1998. 55(11): pp. 1010–6.

    Article  PubMed  Google Scholar 

  19. Simon, N.M., et al., An open-label trial of risperidone augmentation for refractory anxiety disorders. Journal of Clinical Psychiatry, 2006. 67(3): pp. 381–5.

    Article  PubMed  Google Scholar 

  20. Otto, M.W., et al., Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behaviour Research and Therapy, 1999. 37(8): pp. 763–770.

    Article  PubMed  Google Scholar 

  21. Shear, M.K., et al., Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry, 1997. 154(11): pp. 1571–5.

    Article  PubMed  Google Scholar 

  22. Houck, P.R., et al., Reliability of the self-report version of the panic disorder severity scale. Depression & Anxiety, 2002. 15(4): pp. 183–5.

    Article  Google Scholar 

  23. Monkul, E.S., et al., Panic Disorder Severity Scale: reliability and validity of the Turkish version.Depression & Anxiety, 2004. 20(1): pp. 8–16.

    Article  PubMed  Google Scholar 

  24. Yamamoto, I., et al., Cross-cultural evaluation of the Panic Disorder Severity Scale in Japan. Depression & Anxiety, 2004. 20(1): pp. 17–22.

    Article  Google Scholar 

  25. Reiss, S., et al., Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behaviour Research and Therapy, 1986. 24(1): pp. 1–8.

    Article  PubMed  Google Scholar 

  26. Peterson, R.A. and S. Reiss, Anxiety Sensitivity Index. Revised test manual. 1993, Worthington, OH: IDS Publishing Corporation.

    Google Scholar 

  27. Peterson, R.A. and R.L. Heilbronner, The Anxiety Sensitivity Index: Construct validity and factor analytic structure. Journal of Anxiety Disorders, 1987. 1(2): pp. 117–121.

    Article  Google Scholar 

  28. Zinbarg, R.E., et al., Anxiety sensitivity, panic, and depressed mood: A reanalysis teasing apart the contributions of the two levels in the hierarchical structure of the Anxiety Sensitivity Index. Journal of Abnormal Psychology, 2001. 110(3): pp. 372–377.

    Article  PubMed  Google Scholar 

  29. Chambless, D.L., et al., Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. Journal of Consulting & Clinical Psychology, 1984. 52(6): pp. 1090–1097.

    Article  Google Scholar 

  30. Khawaja, N.G., Revisiting the Factor Structure of the Agoraphobic Cognitions Questionnaire and Body Sensations Questionnaire: A Confirmatory Factor Analysis Study. Journal of Psychopathology & Behavioral Assessment, 2003. 25(1): pp. 57–63.

    Article  Google Scholar 

  31. Heimberg, R.G., Cognitive assessment strategies and the measurement of outcome of treatment for social phobia. Behaviour Research and Therapy, 1994. 32(2): pp. 269–280.

    Article  PubMed  Google Scholar 

  32. Liebowitz, M.R. and M.R. Liebowitz, Social phobia. Modern Problems of Pharmacopsychiatry, 1987. 22: pp. 141–73.

    Article  PubMed  Google Scholar 

  33. Mennin, D.S., et al., Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. Journal of Anxiety Disorders, 2002. 16(6): pp. 661–73.

    Article  PubMed  Google Scholar 

  34. Liebowitz, M.R., et al., A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. Journal of Clinical Psychiatry, 2005. 66(2): pp. 238–47.

    Article  PubMed  Google Scholar 

  35. Heimberg, R.G., et al., Psychometric properties of the Liebowitz Social Anxiety Scale. Psychological Medicine, 1999. 29(1): pp. 199–212.

    Article  PubMed  Google Scholar 

  36. Baldwin, D., et al., Paroxetine in social phobia/social anxiety disorder: Randomized, double-blind, placebo-controlled study. British Journal of Psychiatry, 1999. 175(Aug 1999): pp. 120–126, Royal College of Psychiatrists.

    Article  PubMed  Google Scholar 

  37. Bouwer, C. and D.J. Stein, Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia. Journal of Affective Disorders, 1998. 49(1): pp. 79–82.

    Article  PubMed  Google Scholar 

  38. Lott, M., et al., Brofaromine for social phobia: A multicenter, placebo-controlled, double-blind study. Journal of Clinical Psychopharmacology, 1997. 17(4): pp. 255–260.

    Article  PubMed  Google Scholar 

  39. Liebowitz, M.R., et al., Pharmacotherapy of social phobia. A condition distinct from panic attacks. Psychosomatics, 1987. 28(6): pp. 305–8.

    Article  PubMed  Google Scholar 

  40. Safren, S.A., et al., Factor structure of social fears: The Liebowitz Social Anxiety Scale. Journal of Anxiety Disorders, 1999. 13(3): pp. 253–70.

    Article  PubMed  Google Scholar 

  41. Yao, S.N., et al., Social anxiety in patients with social phobia: validation of the Liebowitz social anxiety scale: the French version. Encephale, 1999. 25(5): pp. 429–35.

    PubMed  Google Scholar 

  42. Soykan, C., et al., Liebowitz social anxiety scale: the Turkish version. Psychological Reports, 2003. 93(3 Pt 2): pp. 1059–69.

    Article  PubMed  Google Scholar 

  43. Levin, J.B., et al., Psychometric properties and three proposed subscales of a self-report version of the Liebowitz Social Anxiety Scale translated into Hebrew. Depression & Anxiety, 2002. 16(4): pp. 143–51.

    Article  Google Scholar 

  44. Kobak, K.A., et al., Computer-administered rating scales for social anxiety in a clinical drug trial. [see comment]. Depression & Anxiety, 1998. 7(3): pp. 97–104.

    Article  Google Scholar 

  45. Baker, S.L., et al., The liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis. Behaviour Research & Therapy, 2002. 40(6): pp. 701–15.

    Article  Google Scholar 

  46. Cox, B.J., et al., A comparison of social phobia outcome measures in cognitive-behavioral group therapy. Behavior Modification, 1998. 22(3): pp. 285–97.

    Article  PubMed  Google Scholar 

  47. Fresco, D.M., et al., The Liebowitz social anxiety scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychological Medicine, 2001. 31(6): pp. 1025–1035.

    Article  PubMed  Google Scholar 

  48. Turner, S.M., et al., An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory. Psychological Assessment, 1989. 1: pp. 35–40.

    Article  Google Scholar 

  49. Peters, L. and L. Peters, Discriminant validity of the Social Phobia and Anxiety Inventory (SPAI), the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Behaviour Research & Therapy, 2000. 38(9): pp. 943–50.

    Article  Google Scholar 

  50. Rodebaugh, T.L., et al., Convergent, discriminant, and criterion-related validity of the Social Phobia and Anxiety Inventory. Depression & Anxiety, 2000. 11(1): pp. 10–4.

    Article  Google Scholar 

  51. Beidel, D.C., et al., The social phobia and anxiety inventory: concurrent validity with a clinic sample. Behaviour Research & Therapy, 1989. 27(5): pp. 573–6.

    Article  Google Scholar 

  52. Beidel, D.C., et al., Assessing reliable and clinically significant change in social phobia: validity of the social phobia and anxiety inventory. Behaviour Research & Therapy, 1993. 31(3): pp. 331–7.

    Article  Google Scholar 

  53. Mattick, R.P. and J.C. Clarke, Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behaviour Research & Therapy, 1998. 36(4): pp. 455–70.

    Article  Google Scholar 

  54. Heimberg, R.G., et al., Assessment of anxiety in social interaction and being observed by others: The Social Interaction Anxiety Scale and the Social Phobia Scale. Behavior Therapy, 1992. 23(1): pp. 53–73.

    Article  Google Scholar 

  55. Osman, A., et al., The Social Phobia and Social Interaction Anxiety Scales: Evaluation of psychometric properties. Journal of Psychopathology and Behavioral Assessment, 1998. 20(3): pp. 249–264.

    Article  Google Scholar 

  56. Borkovec, T., The nature, functions, and origins of worry, in Worrying: Perspectives on theory, assessment and treatment. 1994, John Wiley & Sons: Oxford, England. pp. 5–33.

    Google Scholar 

  57. Hamilton, M., Diagnosis and rating of anxiety. British Journal of Psychiatry, 1969. Special Publication No 3.: pp. 76–79.

    Google Scholar 

  58. Hamilton, M., The assessment of anxiety states by rating. British Journal of Medical Psychology, 1959. 32: pp. 50–55.

    Article  PubMed  Google Scholar 

  59. Shear, M.K., et al., Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depression & Anxiety, 2001. 13(4): pp. 166–78.

    Article  Google Scholar 

  60. Kim, T.S., et al., Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder. Psychiatry & Clinical Neurosciences, 2006. 60(3): pp. 347–51.

    Article  Google Scholar 

  61. Brawman-Mintzer, O., et al., Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study.[see comment]. Journal of Clinical Psychiatry, 2005. 66(10): pp. 1321–5.

    Article  PubMed  Google Scholar 

  62. Nimatoudis, I., et al., Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study. International Clinical Psychopharmacology, 2004. 19(6): pp. 331–6.

    Article  PubMed  Google Scholar 

  63. Perugi, G., et al., Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response. Neuropsychobiology, 2002. 46(3): pp. 145–9.

    Article  PubMed  Google Scholar 

  64. Montgomery, S.A., et al., Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR. Journal of Psychiatric Research, 2002. 36(4): pp. 209–17.

    Article  PubMed  Google Scholar 

  65. Meoni, P., et al., Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. Journal of Clinical Psychiatry, 2001. 62(11): pp. 888–93.

    Article  PubMed  Google Scholar 

  66. Moras, K., P.A. di Nardo, and D.H. Barlow, Distinguishing anxiety and depression: Reexamination of the reconstructed Hamilton scales. Psychological Assessment, 1992. 4(2): pp. 224–227.

    Article  Google Scholar 

  67. Kobak, K.A., W.M. Reynolds, and J.H. Greist, Development and validation of a computer-administered version of the Hamilton Rating Scale. Psychological Assessment, 1993. 5(4): pp. 487–492.

    Article  Google Scholar 

  68. Maier, W., et al., The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders, 1988. 14(1): pp. 61–8.

    Article  PubMed  Google Scholar 

  69. Bruss, G.S., et al., Hamilton anxiety rating scale interview guide: joint interview and test-retest methods for interrater reliability. Psychiatry Research, 1994. 53(2): pp. 191–202.

    Article  PubMed  Google Scholar 

  70. Meyer, T., et al., Development and validation of the Penn State worry questionnaire. Behaviour Research and Therapy, 1990. 28(6): pp. 487–495.

    Article  PubMed  Google Scholar 

  71. Spitzer, R.L., et al., A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 2006. 166(10): pp. 1092–7.

    Article  PubMed  Google Scholar 

  72. Goodman, W.K., et al., The Yale-brown obsessive compulsive scale. II. Validity. Archives of General Psychiatry, 1989. 46(11): pp. 1012–6.

    Article  PubMed  Google Scholar 

  73. Goodman, W.K., et al., The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 1989. 46(11): pp. 1006–1011.

    Article  PubMed  Google Scholar 

  74. Tolin, D.F., J.S. Abramowitz, and G.J. Diefenbach, Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale. Journal of Clinical Psychiatry, 2005. 66(12): pp. 1549–1557.

    Article  PubMed  Google Scholar 

  75. DeVeaugh-Geiss, J., P. Landau, and R. Katz, Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder. Psychopharmacological Bulletin, 1989. 25: pp. 36–40.

    Google Scholar 

  76. Steketee, G., et al., The Yale-Brown Obsessive Compulsive Scale: interview versus self-report. Behaviour Research & Therapy, 1996. 34(8): pp. 675–84.

    Article  Google Scholar 

  77. Steketee, G., et al., Psychometric validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory: Part I. Behaviour Research and Therapy, 2003. 41(8): pp. 863–878.

    Article  Google Scholar 

  78. Steketee, G. and R. Frost, Development and initial validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory. Behaviour Research and Therapy, 2001. 39(8): pp. 987–1006.

    Article  Google Scholar 

  79. Aardema, F., K.P. O’Connor, and P.M. Emmelkamp, Inferential Confusion and Obsessive Beliefs in Obsessive-Compulsive Disorder. Cognitive Behaviour Therapy, 2006. 35(3): pp. 138–147.

    Article  PubMed  Google Scholar 

  80. Julien, D., et al., The specificity of belief domains in obsessive-compulsive symptom subtypes. Personality and Individual Differences, 2006. 41(7): pp. 1205–1216.

    Article  Google Scholar 

  81. Taylor, S., D. McKay, and J.S. Abramowitz, Hierarchical structure of dysfunctional beliefs in obsessive-compulsive disorder. Cognitive Behaviour Therapy, 2005. 34(4): pp. 216–228.

    Article  PubMed  Google Scholar 

  82. Taylor, S., J.S. Abramowitz, and D. McKay, Are There Interactions Among Dysfunctional Beliefs in Obsessive Compulsive Disorder? Cognitive Behaviour Therapy, 2005. 34(2): pp. 89–98.

    Article  PubMed  Google Scholar 

  83. Woods, C.M., D.F. Tolin, and J.S. Abramowitz, Dimensionality of the Obsessive Beliefs Questionnaire (OBQ). Journal of Psychopathology and Behavioral Assessment, 2004. 26(2): pp. 113–125.

    Article  Google Scholar 

  84. Foa, E.B., et al., The validation of a new obsessive-compulsive disorder scale: the obsessive-compulsive inventory. Psychological Assessment, 1998. 10(3): pp. 206–214.

    Article  Google Scholar 

  85. Simonds, L.M., S.J. Thorpe, and S.A. Elliott, The Obsessive Compulsive Inventory: psychometric properties in a nonclinical student sample. Behavioural and Cognitive Psychotherapy, 2000. 28(2): pp. 153–159.

    Google Scholar 

  86. Wu, K.D. and D. Watson, Further investigation of the obsessive-compulsive inventory: Psychometric analysis in two non-clinical samples. Journal of Anxiety Disorders, 2003. 17(3): pp. 305–319.

    Article  PubMed  Google Scholar 

  87. Abramowitz, J.S., D.F. Tolin, and G.J. Diefenbach, Measuring Change in OCD: Sensitivity of the Obsessive- Compulsive Inventory-Revised. Journal of Psychopathology and Behavioral Assessment, 2005. 27(4): pp. 317–324.

    Article  Google Scholar 

  88. Abramowitz, J.S. and B.J. Deacon, Psychometric properties and construct validity of the Obsessive-Compulsive Inventory-Revised: Replication and extension with a clinical sample. Journal of Anxiety Disorders, 2006. 20(8): pp. 1016–1035.

    Article  PubMed  Google Scholar 

  89. Rosario-Campos, M.C., et al., The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Molecular Psychiatry, 2006. 11(5): pp. 495–504.

    Article  PubMed  Google Scholar 

  90. Blake, D.D., et al., The development of a Clinician-Administered PTSD Scale. Journal of Traumatic Stress, 1995. 8(1): pp. 75–90.

    Article  PubMed  Google Scholar 

  91. Connor, K.M., et al., SPRINT: a brief global assessment of post-traumatic stress disorder. International Clinical Psychopharmacology, 2001. 16(5): pp. 279–84.

    Article  PubMed  Google Scholar 

  92. Connor, K.M. and J. Davidson, SPRINT: A brief global assessment of post-traumatic stress disorder. International Clinical Psychopharmacology, 2001. 16(5): pp. 279–284.

    Article  PubMed  Google Scholar 

  93. Davidson, J.R., et al., Mirtazapine vs. placebo in posttraumatic stress disorder: A pilot trial. Biological Psychiatry, 2003. 53(2): pp. 188–191.

    Article  PubMed  Google Scholar 

  94. Bahk, W.-M., et al., Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: A pilot study. Human Psychopharmacology: Clinical and Experimental, 2002. 17(7): pp. 341–344.

    Article  Google Scholar 

  95. Kim, W., et al., The effectiveness of mirtazapine in the treatment of post-traumatic stress disorder: a 24-week continuation therapy. Psychiatry and Clinical Neurosciences, 2005. 59(6): pp. 743–747.

    Article  PubMed  Google Scholar 

  96. Vaishnavi, S., et al., A comparison of the SPRINT and CAPS assessment scales for posttraumatic stress disorder. Depression & Anxiety, 2006. 23(7): pp. 437–40.

    Article  Google Scholar 

  97. Davidson, J.R., H.M. Tharwani, and K.M. Connor, Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials. Depression & Anxiety, 2002. 15(2): pp. 75–8.

    Article  Google Scholar 

  98. Foa, E.B., et al., The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychological Assessment, 1997. 9(4): pp. 445–451.

    Article  Google Scholar 

  99. Connor, K.M., et al., Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depression & Anxiety, 2003. 18(2): pp. 76–82.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Body Dysmorphic Disorder Clinic, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Sabine Wilhelm

  2. Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Luana Marques, Anne Chosak Ph.D, Naomi M. Simon M.D, Dieu-My Phan B.A & Mark Pollack M.D

Authors
  1. Luana Marques
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Chosak Ph.D
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naomi M. Simon M.D
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dieu-My Phan B.A
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sabine Wilhelm
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark Pollack M.D
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabine Wilhelm .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Massachusetts General Hospital Harvard Medical School, One Bowdoin Square, Boston, MA, 02114, USA

    Lee Baer  & Mark A. Blais  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Marques, L., Chosak, A., Simon, N.M., Phan, DM., Wilhelm, S., Pollack, M. (2009). Rating Scales for Anxiety Disorders. In: Baer, L., Blais, M.A. (eds) Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Current Clinical Psychiatry. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-387-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-387-5_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-966-6

  • Online ISBN: 978-1-59745-387-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation